INOVIO PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-62.6M | $-65.3M | $2.7M | $10.5M |
| FY2017 | $-63.2M | $-73.5M | $10.3M | $13.1M |
| FY2018 | $-73.6M | $-75.6M | $2.1M | $10.7M |
| FY2019 | $-97.9M | $-98.8M | $987.9K | $10.9M |
| FY2020 | $-178.0M | $-179.5M | $1.5M | $15.6M |
| FY2021 | $-215.7M | $-216.9M | $1.2M | $26.3M |
| FY2022 | $-216.2M | $-217.2M | $969.2K | $22.6M |
| FY2023 | $-124.4M | $-124.7M | $320.9K | $11.1M |
| FY2024 | $-104.1M | $-104.6M | $487.8K | $6.6M |
| FY2025 | $-88.6M | $-88.9M | $285.7K | $3.8M |